Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

[Tissue factor expression of platelets and leukocytes in patients with acute coronary syndromes].

Lu HY, Chen D, Gu J, Song LX, Chen M.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):678-83. doi: 10.7534/j.issn.1009-2137.2013.03.028. Chinese.

PMID:
23815921
2.

Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates.

Brambilla M, Camera M, Colnago D, Marenzi G, De Metrio M, Giesen PL, Balduini A, Veglia F, Gertow K, Biglioli P, Tremoli E.

Arterioscler Thromb Vasc Biol. 2008 May;28(5):947-53. doi: 10.1161/ATVBAHA.107.161471. Epub 2008 Feb 21.

3.

Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.

Ståhl AL, Sartz L, Nelsson A, Békássy ZD, Karpman D.

PLoS One. 2009 Sep 11;4(9):e6990. doi: 10.1371/journal.pone.0006990.

4.

Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome.

Colombo G, Gertow K, Marenzi G, Brambilla M, De Metrio M, Tremoli E, Camera M.

Thromb Res. 2011 Aug;128(2):161-8. doi: 10.1016/j.thromres.2011.02.012. Epub 2011 Mar 21.

PMID:
21420725
5.

Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes.

Song C, Shen Y, Yamen E, Hsu K, Yan W, Witting PK, Geczy CL, Freedman SB.

Atherosclerosis. 2009 Feb;202(2):596-604. doi: 10.1016/j.atherosclerosis.2008.04.049. Epub 2008 May 15.

PMID:
18571179
6.

Platelet-monocyte cross talk and tissue factor expression in stable angina vs. unstable angina/non ST-elevation myocardial infarction.

Kopp CW, Gremmel T, Steiner S, Seidinger D, Minar E, Maurer G, Huber K.

Platelets. 2011;22(7):530-6. doi: 10.3109/09537104.2011.573599. Epub 2011 May 11.

PMID:
21557685
7.
8.

Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expression.

Steiner S, Seidinger D, Huber K, Kaun C, Minar E, Kopp CW.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1697-702. Epub 2003 Jul 17.

9.

[Increased platelet-leukocyte aggregates in patients with acute coronary syndrome].

Yang DH, Tan N, He PC, Liu Y, Wen JY, Chen JY, Zhou YL, Huang WH.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Jun;40(6):482-6. Chinese.

PMID:
22943642
10.

Differences in microparticle release in patients with acute coronary syndrome and stable angina.

Biasucci LM, Porto I, Di Vito L, De Maria GL, Leone AM, Tinelli G, Tritarelli A, Di Rocco G, Snider F, Capogrossi MC, Crea F.

Circ J. 2012;76(9):2174-82. Epub 2012 Jun 5.

11.

Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.

Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S.

Clin Pharmacol Ther. 2003 Mar;73(3):232-41.

PMID:
12621388
12.

Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation.

Gresele P, Falcinelli E, Loffredo F, Cimmino G, Corazzi T, Forte L, Guglielmini G, Momi S, Golino P.

Eur Heart J. 2011 Feb;32(3):316-25. doi: 10.1093/eurheartj/ehq390. Epub 2010 Oct 28.

13.

Material-induced tissue factor expression but not CD11b upregulation depends on the presence of platelets.

Gorbet MB, Sefton MV.

J Biomed Mater Res A. 2003 Dec 1;67(3):792-800.

PMID:
14613227
14.

The role of platelets CD40 ligand (CD154) in acute coronary syndromes.

Abu el-Makrem MA, Mahmoud YZ, Sayed D, Nassef NM, Abd el-Kader SS, Zakhary M, Ghazaly T, Matta R.

Thromb Res. 2009 Dec;124(6):683-8. doi: 10.1016/j.thromres.2009.06.028. Epub 2009 Aug 4.

PMID:
19656553
15.

Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes.

Jiang DJ, Cao Y, Xin HY, Li XH, Luo ZQ, Li YJ.

Atherosclerosis. 2009 Aug;205(2):554-60. doi: 10.1016/j.atherosclerosis.2008.12.024. Epub 2008 Dec 25.

PMID:
19167713
16.

Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation.

Zillmann A, Luther T, Müller I, Kotzsch M, Spannagl M, Kauke T, Oelschlägel U, Zahler S, Engelmann B.

Biochem Biophys Res Commun. 2001 Feb 23;281(2):603-9.

PMID:
11181090
17.

P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.

Zhao L, Bath PM, May J, Lösche W, Heptinstall S.

Platelets. 2003 Nov-Dec;14(7-8):473-80. Erratum in: Platelets. 2004 Feb;15(1):63.

PMID:
14713516
18.

Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypass.

Shibamiya A, Tabuchi N, Chung J, Sunamori M, Koyama T.

Thromb Haemost. 2004 Jul;92(1):124-31.

PMID:
15213853
19.

Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.

Czyz A, Kołacz E, Angerer D, Zawilska K.

Kardiol Pol. 2005 Mar;62(3):189-200; discussion 201. English, Polish.

PMID:
15830013
20.

The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome.

Liu DM, Yan JC, Wang CP, Chen GH, Ding S, Liu PJ, Du RZ.

Clin Chim Acta. 2008 Nov;397(1-2):22-6. doi: 10.1016/j.cca.2008.07.003. Epub 2008 Jul 12.

PMID:
18674525
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk